ATOSSA THERAPEUTICS, INC.: 10-Q filed 2017-11-13

Name: ATOSSA THERAPEUTICS, INC.: 10-Q filed 2017-11-13
Creator: ATOSSA THERAPEUTICS, INC.

What ATOSSA THERAPEUTICS, INC. reported in its quarterly report filed 2017-11-13 (fiscal Q3 2017): 30 published measures, 75 facts as tagged in accession 0001615774-17-006519.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-11-13
Fiscal period: fiscal Q3 2017
Accession: 0001615774-17-006519 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ATOSSA THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-09-30	3,634,621	USD
At 2016-12-31	4,144,372	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2017-09-30	2,562,798	USD
At 2016-12-31	3,097,106	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-09-30	2,733,663	USD
At 2016-12-31	3,027,962	USD
At 2016-09-30	4,388,177	USD
At 2015-12-31	3,715,895	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-2,184,510	USD	92
2017-01-01 to 2017-09-30	-6,129,553	USD	273
2016-07-01 to 2016-09-30	204,689	USD	92
2016-01-01 to 2016-09-30	-3,845,235	USD	274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	-4,911,268	USD	273
2016-01-01 to 2016-09-30	-4,018,564	USD	274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	4,616,969	USD	273
2016-01-01 to 2016-09-30	4,695,869	USD	274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-5,023	USD	274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-09-30	-63,433,301	USD
At 2016-12-31	-57,303,748	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-09-30	14,435	USD
At 2016-12-31	55,119	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-2,055,927	USD	92
2017-01-01 to 2017-09-30	-5,639,035	USD	273
2016-07-01 to 2016-09-30	-1,558,435	USD	92
2016-01-01 to 2016-09-30	-5,444,902	USD	274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-09-30	2,950,109	USD
At 2016-12-31	3,254,563	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-09-30	1,071,823	USD
At 2016-12-31	1,047,266	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-09-30	380,399	USD
At 2016-12-31	254,320	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2017-09-30	561,354	USD
At 2016-12-31	640,440	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	2,055,927	USD	92
2017-01-01 to 2017-09-30	5,639,035	USD	273
2016-07-01 to 2016-09-30	1,558,435	USD	92
2016-01-01 to 2016-09-30	5,444,902	USD	274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	742,450	USD	92
2017-01-01 to 2017-09-30	2,110,846	USD	273
2016-07-01 to 2016-09-30	85,000	USD	92
2016-01-01 to 2016-09-30	403,963	USD	274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2017-09-30	14,022,741	shares
At 2016-12-31	3,786,913	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2017-09-30	65,785,758	USD
At 2016-12-31	60,344,050	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2017-09-30	170,917	USD
At 2016-12-31	210,528	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2017-09-30	156,482	USD
At 2016-12-31	155,409	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-09-30	108,723	USD
At 2016-12-31	194,250	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-09-30	50,542	USD
At 2016-12-31	16,964	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-2,184,510	USD	92
2017-01-01 to 2017-09-30	-8,697,685	USD	273
2016-07-01 to 2016-09-30	204,689	USD	92
2016-01-01 to 2016-09-30	-3,845,235	USD	274

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	1,313,477	USD	92
2017-01-01 to 2017-09-30	3,528,189	USD	273
2016-07-01 to 2016-09-30	1,473,435	USD	92
2016-01-01 to 2016-09-30	5,040,939	USD	274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	4,554	USD	92
2017-01-01 to 2017-09-30	22,988	USD	273
2016-07-01 to 2016-09-30	29,698	USD	92
2016-01-01 to 2016-09-30	92,054	USD	274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	102,074	USD	273
2016-01-01 to 2016-09-30	227,387	USD	274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2017-07-01 to 2017-09-30	-283	USD	92
2017-01-01 to 2017-09-30	-16,954	USD	273
2016-07-01 to 2016-09-30	1,763,124	USD	92
2016-01-01 to 2016-09-30	1,599,667	USD	274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,304	USD	274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	4,695,869	USD	274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-09-30	126,079	USD	273
2016-01-01 to 2016-09-30	-617,094	USD	274

Inspect the source

Entity: ATOSSA THERAPEUTICS, INC. / CIK 0001488039
Captured: 2026-09-20T09:09:43.864Z
SEC response SHA-256: 1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))